Fig. 6From: Treatment of a chemoresistant neuroblastoma cell line with the antimalarial ozonide OZ513a MYCN, b capase-3 and cleaved capase-3, c CyclinD1, and d PARP and cleaved PARP protein after treatment with 0.5, 1, and 2.5 mcg/ml OZ513. Treatment and control diluted in 0.01Â % DMSO in growth mediaBack to article page